The American insurance behemoth Progressive finds itself navigating turbulent waters. Despite encouraging customer acquisition figures, market experts remain divided, and corporate insiders are significantly reducing their holdings. The central question for investors is whether the company can engineer a sustainable recovery or if further declines are imminent.
A Surge in Policyholder Growth
A glimmer of hope emerged in Progressive’s October operational data. The company’s core auto insurance business attracted 273,000 new customers, representing its third-strongest monthly performance for the year and a notable improvement over September’s results. This customer growth was complemented by a substantial leap in profitability, with net income doubling year-over-year to reach $846 million. However, this positive monthly snapshot is set against the backdrop of a recent quarterly earnings miss, leaving the stock trading approximately 28% below its annual peak. For a true reversal of fortune, the positive October trends must be confirmed in the upcoming quarterly reports.
Divergent Voices from the Analyst Community
The outlook from financial research firms is anything but unanimous, creating a cloud of uncertainty. In a display of conflicting sentiment, BMO Capital Markets raised its price target to $260, while simultaneously, Goldman Sachs and UBS adopted a more cautious stance. Goldman Sachs executed a significant reduction, slashing its target from $276 to $245. Although the consensus average price target of $266.52 suggests a potential upside of nearly 20%, this wide disparity in expert opinion highlights the deep uncertainty over whether Progressive has bottomed out or still faces significant headwinds.
Should investors sell immediately? Or is it worth buying Progressive?
Insider Selling and Institutional Reshuffling
While analysts debate, the actions of those with intimate company knowledge speak volumes. CEO Susan Patricia Griffith led the way in September, divesting shares valued at over $7.5 million, which reduced her personal stake by six percent. Two other top executives followed suit, also selling portions of their holdings.
The institutional investment landscape is also undergoing a significant transformation. Firms like American Century and Franklin Resources have substantially downsized their positions. On the other side of the trade, Norges Bank made a massive new investment, and Capital International Investors dramatically increased its exposure by almost 80 percent. This churn indicates a fundamental disagreement among major shareholders about Progressive’s future trajectory. The coming months will be critical in determining which side of this trade is proven correct.
Ad
Progressive Stock: Buy or Sell?! New Progressive Analysis from November 23 delivers the answer:
The latest Progressive figures speak for themselves: Urgent action needed for Progressive investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 23.
Progressive: Buy or sell? Read more here...









